Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 2

1(12.5%)

8Total

N/A(7)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05237921Not ApplicableCompleted

Adherence to Exercise and Dietary Intervention in Cancer Patients

Role: lead

NCT05420259Not ApplicableRecruiting

Combined Exercise and Nutritional Intervention in GI Cancer Patients

Role: lead

NCT04646902Unknown

Kynurenine/Tryptophan Ratio in Hypertension Associated to Obstructive Sleep Apnea

Role: collaborator

NCT03860324Not ApplicableWithdrawn

Erector Spinae vs Fascia Iliaca Block in Hip Arthroplasty

Role: lead

NCT03856957Not ApplicableCompleted

Serrated Lesions Detection With Endocuff-assisted Colonoscopy

Role: lead

NCT03915756Not ApplicableUnknown

Postoperative Drainage in Total Knee Arthroplasty in the Presence of Tranexamic Acid

Role: lead

NCT03726281Phase 2Withdrawn

Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors

Role: lead

NCT02876133Not ApplicableUnknown

Narrow Band Imaging Versus White Light for Colonoscopy Serrate Lesions Detection

Role: lead

NCT02067065Not ApplicableCompleted

Non-anesthesiologist Administered Propofol Sedation for Colonoscopy - a Randomized Clinical Trial

Role: lead

All 9 trials loaded